Collaborative Cohort of Cohorts for COVID Research
@C4RStudy
C4R is an @NIH study to understand the impacts of COVID-19 on health in a racially and ethnically diverse cohort of 47,000+ participants. Likes ≠ Endorsement
In older, community-dwelling US adults, systemic symptoms following #SARSCoV2 mRNA vaccination were associated with greater antibody response, suggesting that post-vaccination symptoms should be reframed as signals of vaccine effectiveness. @C4Rstudy https://t.co/7LeO3sccto
#C4R is at #ATS2022 in San Francisco! Please join our 12 PM session in Room 3006/3008 (West Building, Level 3) at the Moscone Center to learn more about our research
Read how #C4R will support evaluation of risk & resilience factors for #COVID severity & other outcomes, including #PASC, from our study design paper just published in @AmJEpi
https://t.co/rZEmKsN7HN
Covid patients lost more gray matter and experienced more brain tissue damage than people who didn’t get Covid, according to a new study that analyzed brain scans in patients before and months after their infection. https://t.co/iR3vaAHK8e
Among patients who had recovered from Covid-19, the receipt of at least one dose of the BNT162b2 vaccine was associated with a significantly lower risk of recurrent infection. https://t.co/AAlsY9sFlv
Among more than 35,000 health care workers, those who received two doses of BNT162b2 vaccine had a high level of protection against serious #COVID19, regardless of the between-dose interval, but efficacy began to wane after 6 months. https://t.co/dAxiLwZN1x
Study suggests receipt of 3 doses of mRNA #COVID19 vaccine, vs 2 doses or being unvaccinated, was associated with protection against both the Omicron and Delta variants; higher odds ratios for Omicron suggest less protection for Omicron than for Delta. https://t.co/GdUomNGSKh
Many #REGARDSStudy participants with potential #COVID19 symptoms and asymptomatic who desired testing did not receive COVID-19 testing. Findings by #C4R investigator @EmilyLevitan published in BMC Public Health.
https://t.co/uPVid1w43b
Congratulations to our #C4R Early Career Investigator Awardees 🥳@deborascience@priyapalta @Jana_Hirsch @lilahbesser @marciaixchel who will be analyzing data from over 47,000 US adults to better understand #COVID19 risk & resilience
Our C4R design paper is available on medRxiv - read more about the goals and structure of C4R and our participants here https://t.co/XIFzkw4J3k. #C4R#COVID19
#C4R is linking information on #COVID illness, #longCOVID, #vaccination, #antibodies, and other pandemic-related experiences, to decades of pre-COVID data on clinical and subclinical diseases, behavior, cognition, biomarkers, #imaging, #Omics and #SDOH.
#C4R aims to identify risk & resilience factors for #COVID19 severity and long-term health effects. It is a collaboration of 14 ongoing observational studies funded by @nih_nhlbi, @NINDSfunding, and @NIHAging